Starpharma Institutional ownership
What is the Institutional ownership of Starpharma?
The Institutional ownership of Starpharma Holdings Limited is 42.81%
What is the definition of Institutional ownership?
Institutional Ownership is the amount of a company’s available stock owned by mutual or pension funds, insurance companies, investment firms, endowments or other large entities that manage funds on the behalf of others.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutional ownership of companies in the Health Care sector on ASX compared to Starpharma
What does Starpharma do?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Companies with institutional ownership similar to Starpharma
- T-Mobile US has Institutional ownership of 42.78%
- Rubis SCA has Institutional ownership of 42.78%
- Orora has Institutional ownership of 42.79%
- Sculptor Capital Management has Institutional ownership of 42.79%
- Sculptor Capital Management has Institutional ownership of 42.79%
- The Great Eastern Shipping has Institutional ownership of 42.80%
- Starpharma has Institutional ownership of 42.81%
- Dish TV India has Institutional ownership of 42.82%
- Middlefield Canadian Income PCC has Institutional ownership of 42.83%
- Fuelcell Inc has Institutional ownership of 42.84%
- Grupo Televisa SAB has Institutional ownership of 42.84%
- UniCredit SpA has Institutional ownership of 42.85%
- W & T Offshore Inc has Institutional ownership of 42.85%